• レポートコード:GIR-107A12405 • 出版社/出版日:GlobalInfoResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態:英文、PDF、91ページ • 納品方法:Eメール(納期:2~3日) • 産業分類:医療 |
Single User | ¥522,000 (USD3,480) | ▷ お問い合わせ |
Multi User | ¥783,000 (USD5,220) | ▷ お問い合わせ |
Corporate User | ¥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
当調査資料では、体外毒性試験のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。体外毒性試験の種類別市場規模(細胞アッセイ、生化学的アッセイ、シリカ中、ex-vivo)、用途別市場規模(全身毒性、皮膚毒性、内分泌かく乱、眼毒性、その他)、地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど)、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・体外毒性試験の市場概要 ・企業情報(企業概要、製品概要、販売量、価格、売上):Abbott、Covance、GE Healthcare、Quest Diagnostics Inc.、Thermo Fisher Scientific Inc.、Bio-Rad Laboratories、Catalent Pharma Solutions、Cyprotex、Agilent Technologies、Charles River Laboratories、Merck KgaA、Eurofins Scientific Inc. ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年:細胞アッセイ、生化学的アッセイ、シリカ中、ex-vivo ・用途別分析2016年-2026年:全身毒性、皮膚毒性、内分泌かく乱、眼毒性、その他 ・体外毒性試験の北米市場規模2016年-2026年:アメリカ、カナダ、メキシコ ・体外毒性試験のヨーロッパ市場規模2016年-2026年:ドイツ、イギリス、フランス、ロシア、イタリア ・体外毒性試験のアジア市場規模2016年-2026年:中国、日本、韓国、インド、東南アジア、オーストラリア ・体外毒性試験の南米市場規模2016年-2026年:ブラジル、アルゼンチン ・体外毒性試験の中東・アフリカ市場規模2016年-2026年:サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The In-vitro Toxicology Testing market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global In-vitro Toxicology Testing size is estimated to be USD 13820 million in 2026 from USD 10870 million in 2020, with a change XX% between 2020 and 2021. The global In-vitro Toxicology Testing market size is expected to grow at a CAGR of 6.2% for the next five years.
Market segmentation
In-vitro Toxicology Testing market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Cellular Assay
Biochemical Assay
In Silica
Ex-vivo
Market segment by Application, can be divided into
Systemic Toxicology
Dermal Toxicity
Endocrine Disruption
Ocular Toxicity
Others
Market segment by players, this report covers
Abbott
Covance
GE Healthcare
Quest Diagnostics Inc.
Thermo Fisher Scientific Inc.
Bio-Rad Laboratories
Catalent Pharma Solutions
Cyprotex
Agilent Technologies
Charles River Laboratories
Merck KgaA
Eurofins Scientific Inc.
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe In-vitro Toxicology Testing product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of In-vitro Toxicology Testing, with revenue, gross margin and global market share of In-vitro Toxicology Testing from 2019 to 2021.
Chapter 3, the In-vitro Toxicology Testing competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by type and application, with revenue and growth rate by type, application, from 2016 to 2026.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2016 to 2021.and In-vitro Toxicology Testing market forecast, by regions, type and application, with revenue, from 2021 to 2026.
Chapter 11 and 12, to describe In-vitro Toxicology Testing research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Product Overview and Scope of In-vitro Toxicology Testing
1.2 Classification of In-vitro Toxicology Testing by Type
1.2.1 Overview: Global In-vitro Toxicology Testing Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global In-vitro Toxicology Testing Revenue Market Share by Type in 2020
1.2.3 Cellular Assay
1.2.4 Biochemical Assay
1.2.5 In Silica
1.2.6 Ex-vivo
1.3 Global In-vitro Toxicology Testing Market by Application
1.3.1 Overview: Global In-vitro Toxicology Testing Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Systemic Toxicology
1.3.3 Dermal Toxicity
1.3.4 Endocrine Disruption
1.3.5 Ocular Toxicity
1.3.6 Others
1.4 Global In-vitro Toxicology Testing Market Size & Forecast
1.5 Global In-vitro Toxicology Testing Market Size and Forecast by Region
1.5.1 Global In-vitro Toxicology Testing Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global In-vitro Toxicology Testing Market Size by Region, (2016-2021)
1.5.3 North America In-vitro Toxicology Testing Market Size and Prospect (2016-2026)
1.5.4 Europe In-vitro Toxicology Testing Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific In-vitro Toxicology Testing Market Size and Prospect (2016-2026)
1.5.6 South America In-vitro Toxicology Testing Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa In-vitro Toxicology Testing Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 In-vitro Toxicology Testing Market Drivers
1.6.2 In-vitro Toxicology Testing Market Restraints
1.6.3 In-vitro Toxicology Testing Trends Analysis
2 Company Profiles
2.1 Abbott
2.1.1 Abbott Details
2.1.2 Abbott Major Business
2.1.3 Abbott In-vitro Toxicology Testing Product and Solutions
2.1.4 Abbott In-vitro Toxicology Testing Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Abbott Recent Developments and Future Plans
2.2 Covance
2.2.1 Covance Details
2.2.2 Covance Major Business
2.2.3 Covance In-vitro Toxicology Testing Product and Solutions
2.2.4 Covance In-vitro Toxicology Testing Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Covance Recent Developments and Future Plans
2.3 GE Healthcare
2.3.1 GE Healthcare Details
2.3.2 GE Healthcare Major Business
2.3.3 GE Healthcare In-vitro Toxicology Testing Product and Solutions
2.3.4 GE Healthcare In-vitro Toxicology Testing Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 GE Healthcare Recent Developments and Future Plans
2.4 Quest Diagnostics Inc.
2.4.1 Quest Diagnostics Inc. Details
2.4.2 Quest Diagnostics Inc. Major Business
2.4.3 Quest Diagnostics Inc. In-vitro Toxicology Testing Product and Solutions
2.4.4 Quest Diagnostics Inc. In-vitro Toxicology Testing Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Quest Diagnostics Inc. Recent Developments and Future Plans
2.5 Thermo Fisher Scientific Inc.
2.5.1 Thermo Fisher Scientific Inc. Details
2.5.2 Thermo Fisher Scientific Inc. Major Business
2.5.3 Thermo Fisher Scientific Inc. In-vitro Toxicology Testing Product and Solutions
2.5.4 Thermo Fisher Scientific Inc. In-vitro Toxicology Testing Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Thermo Fisher Scientific Inc. Recent Developments and Future Plans
2.6 Bio-Rad Laboratories
2.6.1 Bio-Rad Laboratories Details
2.6.2 Bio-Rad Laboratories Major Business
2.6.3 Bio-Rad Laboratories In-vitro Toxicology Testing Product and Solutions
2.6.4 Bio-Rad Laboratories In-vitro Toxicology Testing Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Bio-Rad Laboratories Recent Developments and Future Plans
2.7 Catalent Pharma Solutions
2.7.1 Catalent Pharma Solutions Details
2.7.2 Catalent Pharma Solutions Major Business
2.7.3 Catalent Pharma Solutions In-vitro Toxicology Testing Product and Solutions
2.7.4 Catalent Pharma Solutions In-vitro Toxicology Testing Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Catalent Pharma Solutions Recent Developments and Future Plans
2.8 Cyprotex
2.8.1 Cyprotex Details
2.8.2 Cyprotex Major Business
2.8.3 Cyprotex In-vitro Toxicology Testing Product and Solutions
2.8.4 Cyprotex In-vitro Toxicology Testing Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Cyprotex Recent Developments and Future Plans
2.9 Agilent Technologies
2.9.1 Agilent Technologies Details
2.9.2 Agilent Technologies Major Business
2.9.3 Agilent Technologies In-vitro Toxicology Testing Product and Solutions
2.9.4 Agilent Technologies In-vitro Toxicology Testing Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Agilent Technologies Recent Developments and Future Plans
2.10 Charles River Laboratories
2.10.1 Charles River Laboratories Details
2.10.2 Charles River Laboratories Major Business
2.10.3 Charles River Laboratories In-vitro Toxicology Testing Product and Solutions
2.10.4 Charles River Laboratories In-vitro Toxicology Testing Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 Charles River Laboratories Recent Developments and Future Plans
2.11 Merck KgaA
2.11.1 Merck KgaA Details
2.11.2 Merck KgaA Major Business
2.11.3 Merck KgaA In-vitro Toxicology Testing Product and Solutions
2.11.4 Merck KgaA In-vitro Toxicology Testing Revenue, Gross Margin and Market Share (2019-2021)
2.11.5 Merck KgaA Recent Developments and Future Plans
2.12 Eurofins Scientific Inc.
2.12.1 Eurofins Scientific Inc. Details
2.12.2 Eurofins Scientific Inc. Major Business
2.12.3 Eurofins Scientific Inc. In-vitro Toxicology Testing Product and Solutions
2.12.4 Eurofins Scientific Inc. In-vitro Toxicology Testing Revenue, Gross Margin and Market Share (2019-2021)
2.12.5 Eurofins Scientific Inc. Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global In-vitro Toxicology Testing Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 In-vitro Toxicology Testing Players Market Share
3.2.2 Top 10 In-vitro Toxicology Testing Players Market Share
3.2.3 Market Competition Trend
3.3 In-vitro Toxicology Testing Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global In-vitro Toxicology Testing Revenue and Market Share by Type (2016-2021)
4.2 Global In-vitro Toxicology Testing Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global In-vitro Toxicology Testing Revenue Market Share by Application (2016-2021)
5.2 In-vitro Toxicology Testing Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America In-vitro Toxicology Testing Revenue by Type (2016-2026)
6.2 North America In-vitro Toxicology Testing Revenue by Application (2016-2026)
6.3 North America In-vitro Toxicology Testing Market Size by Country
6.3.1 North America In-vitro Toxicology Testing Revenue by Country (2016-2026)
6.3.2 United States In-vitro Toxicology Testing Market Size and Forecast (2016-2026)
6.3.3 Canada In-vitro Toxicology Testing Market Size and Forecast (2016-2026)
6.3.4 Mexico In-vitro Toxicology Testing Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe In-vitro Toxicology Testing Revenue by Type (2016-2026)
7.2 Europe In-vitro Toxicology Testing Revenue by Application (2016-2026)
7.3 Europe In-vitro Toxicology Testing Market Size by Country
7.3.1 Europe In-vitro Toxicology Testing Revenue by Country (2016-2026)
7.3.2 Germany In-vitro Toxicology Testing Market Size and Forecast (2016-2026)
7.3.3 France In-vitro Toxicology Testing Market Size and Forecast (2016-2026)
7.3.4 United Kingdom In-vitro Toxicology Testing Market Size and Forecast (2016-2026)
7.3.5 Russia In-vitro Toxicology Testing Market Size and Forecast (2016-2026)
7.3.6 Italy In-vitro Toxicology Testing Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific In-vitro Toxicology Testing Revenue by Type (2016-2026)
8.2 Asia-Pacific In-vitro Toxicology Testing Revenue by Application (2016-2026)
8.3 Asia-Pacific In-vitro Toxicology Testing Market Size by Region
8.3.1 Asia-Pacific In-vitro Toxicology Testing Revenue by Region (2016-2026)
8.3.2 China In-vitro Toxicology Testing Market Size and Forecast (2016-2026)
8.3.3 Japan In-vitro Toxicology Testing Market Size and Forecast (2016-2026)
8.3.4 South Korea In-vitro Toxicology Testing Market Size and Forecast (2016-2026)
8.3.5 India In-vitro Toxicology Testing Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia In-vitro Toxicology Testing Market Size and Forecast (2016-2026)
8.3.7 Australia In-vitro Toxicology Testing Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America In-vitro Toxicology Testing Revenue by Type (2016-2026)
9.2 South America In-vitro Toxicology Testing Revenue by Application (2016-2026)
9.3 South America In-vitro Toxicology Testing Market Size by Country
9.3.1 South America In-vitro Toxicology Testing Revenue by Country (2016-2026)
9.3.2 Brazil In-vitro Toxicology Testing Market Size and Forecast (2016-2026)
9.3.3 Argentina In-vitro Toxicology Testing Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa In-vitro Toxicology Testing Revenue by Type (2016-2026)
10.2 Middle East & Africa In-vitro Toxicology Testing Revenue by Application (2016-2026)
10.3 Middle East & Africa In-vitro Toxicology Testing Market Size by Country
10.3.1 Middle East & Africa In-vitro Toxicology Testing Revenue by Country (2016-2026)
10.3.2 Turkey In-vitro Toxicology Testing Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia In-vitro Toxicology Testing Market Size and Forecast (2016-2026)
10.3.4 UAE In-vitro Toxicology Testing Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
Table 1. Global In-vitro Toxicology Testing Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global In-vitro Toxicology Testing Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market In-vitro Toxicology Testing Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global In-vitro Toxicology Testing Revenue (USD Million) by Region (2016-2021)
Table 5. Global In-vitro Toxicology Testing Revenue Market Share by Region (2021-2026)
Table 6. Abbott Corporate Information, Head Office, and Major Competitors
Table 7. Abbott Major Business
Table 8. Abbott In-vitro Toxicology Testing Product and Solutions
Table 9. Abbott In-vitro Toxicology Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Covance Corporate Information, Head Office, and Major Competitors
Table 11. Covance Major Business
Table 12. Covance In-vitro Toxicology Testing Product and Solutions
Table 13. Covance In-vitro Toxicology Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. GE Healthcare Corporate Information, Head Office, and Major Competitors
Table 15. GE Healthcare Major Business
Table 16. GE Healthcare In-vitro Toxicology Testing Product and Solutions
Table 17. GE Healthcare In-vitro Toxicology Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Quest Diagnostics Inc. Corporate Information, Head Office, and Major Competitors
Table 19. Quest Diagnostics Inc. Major Business
Table 20. Quest Diagnostics Inc. In-vitro Toxicology Testing Product and Solutions
Table 21. Quest Diagnostics Inc. In-vitro Toxicology Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Thermo Fisher Scientific Inc. Corporate Information, Head Office, and Major Competitors
Table 23. Thermo Fisher Scientific Inc. Major Business
Table 24. Thermo Fisher Scientific Inc. In-vitro Toxicology Testing Product and Solutions
Table 25. Thermo Fisher Scientific Inc. In-vitro Toxicology Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Bio-Rad Laboratories Corporate Information, Head Office, and Major Competitors
Table 27. Bio-Rad Laboratories Major Business
Table 28. Bio-Rad Laboratories In-vitro Toxicology Testing Product and Solutions
Table 29. Bio-Rad Laboratories In-vitro Toxicology Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Catalent Pharma Solutions Corporate Information, Head Office, and Major Competitors
Table 31. Catalent Pharma Solutions Major Business
Table 32. Catalent Pharma Solutions In-vitro Toxicology Testing Product and Solutions
Table 33. Catalent Pharma Solutions In-vitro Toxicology Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Cyprotex Corporate Information, Head Office, and Major Competitors
Table 35. Cyprotex Major Business
Table 36. Cyprotex In-vitro Toxicology Testing Product and Solutions
Table 37. Cyprotex In-vitro Toxicology Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Agilent Technologies Corporate Information, Head Office, and Major Competitors
Table 39. Agilent Technologies Major Business
Table 40. Agilent Technologies In-vitro Toxicology Testing Product and Solutions
Table 41. Agilent Technologies In-vitro Toxicology Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. Charles River Laboratories Corporate Information, Head Office, and Major Competitors
Table 43. Charles River Laboratories Major Business
Table 44. Charles River Laboratories In-vitro Toxicology Testing Product and Solutions
Table 45. Charles River Laboratories In-vitro Toxicology Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 46. Merck KgaA Corporate Information, Head Office, and Major Competitors
Table 47. Merck KgaA Major Business
Table 48. Merck KgaA In-vitro Toxicology Testing Product and Solutions
Table 49. Merck KgaA In-vitro Toxicology Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 50. Eurofins Scientific Inc. Corporate Information, Head Office, and Major Competitors
Table 51. Eurofins Scientific Inc. Major Business
Table 52. Eurofins Scientific Inc. In-vitro Toxicology Testing Product and Solutions
Table 53. Eurofins Scientific Inc. In-vitro Toxicology Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 54. Global In-vitro Toxicology Testing Revenue (USD Million) by Players (2019-2021)
Table 55. Global In-vitro Toxicology Testing Revenue Share by Players (2019-2021)
Table 56. Breakdown of In-vitro Toxicology Testing by Company Type (Tier 1, Tier 2 and Tier 3)
Table 57. In-vitro Toxicology Testing Players Head Office, Products and Services Provided
Table 58. In-vitro Toxicology Testing Mergers & Acquisitions in the Past Five Years
Table 59. In-vitro Toxicology Testing New Entrants and Expansion Plans
Table 60. Global In-vitro Toxicology Testing Revenue (USD Million) by Type (2016-2021)
Table 61. Global In-vitro Toxicology Testing Revenue Share by Type (2016-2021)
Table 62. Global In-vitro Toxicology Testing Revenue Forecast by Type (2021-2026)
Table 63. Global In-vitro Toxicology Testing Revenue by Application (2016-2021)
Table 64. Global In-vitro Toxicology Testing Revenue Forecast by Application (2021-2026)
Table 65. North America In-vitro Toxicology Testing Revenue by Type (2016-2021) & (USD Million)
Table 66. North America In-vitro Toxicology Testing Revenue by Type (2021-2026) & (USD Million)
Table 67. North America In-vitro Toxicology Testing Revenue by Application (2016-2021) & (USD Million)
Table 68. North America In-vitro Toxicology Testing Revenue by Application (2021-2026) & (USD Million)
Table 69. North America In-vitro Toxicology Testing Revenue by Country (2016-2021) & (USD Million)
Table 70. North America In-vitro Toxicology Testing Revenue by Country (2021-2026) & (USD Million)
Table 71. Europe In-vitro Toxicology Testing Revenue by Type (2016-2021) & (USD Million)
Table 72. Europe In-vitro Toxicology Testing Revenue by Type (2021-2026) & (USD Million)
Table 73. Europe In-vitro Toxicology Testing Revenue by Application (2016-2021) & (USD Million)
Table 74. Europe In-vitro Toxicology Testing Revenue by Application (2021-2026) & (USD Million)
Table 75. Europe In-vitro Toxicology Testing Revenue by Country (2016-2021) & (USD Million)
Table 76. Europe In-vitro Toxicology Testing Revenue by Country (2021-2026) & (USD Million)
Table 77. Asia-Pacific In-vitro Toxicology Testing Revenue by Type (2016-2021) & (USD Million)
Table 78. Asia-Pacific In-vitro Toxicology Testing Revenue by Type (2021-2026) & (USD Million)
Table 79. Asia-Pacific In-vitro Toxicology Testing Revenue by Application (2016-2021) & (USD Million)
Table 80. Asia-Pacific In-vitro Toxicology Testing Revenue by Application (2021-2026) & (USD Million)
Table 81. Asia-Pacific In-vitro Toxicology Testing Revenue by Region (2016-2021) & (USD Million)
Table 82. Asia-Pacific In-vitro Toxicology Testing Revenue by Region (2021-2026) & (USD Million)
Table 83. South America In-vitro Toxicology Testing Revenue by Type (2016-2021) & (USD Million)
Table 84. South America In-vitro Toxicology Testing Revenue by Type (2021-2026) & (USD Million)
Table 85. South America In-vitro Toxicology Testing Revenue by Application (2016-2021) & (USD Million)
Table 86. South America In-vitro Toxicology Testing Revenue by Application (2021-2026) & (USD Million)
Table 87. South America In-vitro Toxicology Testing Revenue by Country (2016-2021) & (USD Million)
Table 88. South America In-vitro Toxicology Testing Revenue by Country (2021-2026) & (USD Million)
Table 89. Middle East & Africa In-vitro Toxicology Testing Revenue by Type (2016-2021) & (USD Million)
Table 90. Middle East & Africa In-vitro Toxicology Testing Revenue by Type (2021-2026) & (USD Million)
Table 91. Middle East & Africa In-vitro Toxicology Testing Revenue by Application (2016-2021) & (USD Million)
Table 92. Middle East & Africa In-vitro Toxicology Testing Revenue by Application (2021-2026) & (USD Million)
Table 93. Middle East & Africa In-vitro Toxicology Testing Revenue by Country (2016-2021) & (USD Million)
Table 94. Middle East & Africa In-vitro Toxicology Testing Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. In-vitro Toxicology Testing Picture
Figure 2. Global In-vitro Toxicology Testing Revenue Market Share by Type in 2020
Figure 3. Cellular Assay
Figure 4. Biochemical Assay
Figure 5. In Silica
Figure 6. Ex-vivo
Figure 7. In-vitro Toxicology Testing Revenue Market Share by Application in 2020
Figure 8. Systemic Toxicology Picture
Figure 9. Dermal Toxicity Picture
Figure 10. Endocrine Disruption Picture
Figure 11. Ocular Toxicity Picture
Figure 12. Others Picture
Figure 13. Global In-vitro Toxicology Testing Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 14. Global In-vitro Toxicology Testing Revenue and Forecast (2016-2026) & (USD Million)
Figure 15. Global In-vitro Toxicology Testing Revenue Market Share by Region (2016-2026)
Figure 16. Global In-vitro Toxicology Testing Revenue Market Share by Region in 2020
Figure 17. North America In-vitro Toxicology Testing Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. Europe In-vitro Toxicology Testing Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. Asia-Pacific In-vitro Toxicology Testing Revenue (USD Million) and Growth Rate (2016-2026)
Figure 20. South America In-vitro Toxicology Testing Revenue (USD Million) and Growth Rate (2016-2026)
Figure 21. Middle East and Africa In-vitro Toxicology Testing Revenue (USD Million) and Growth Rate (2016-2026)
Figure 22. In-vitro Toxicology Testing Market Drivers
Figure 23. In-vitro Toxicology Testing Market Restraints
Figure 24. In-vitro Toxicology Testing Market Trends
Figure 25. Abbott Recent Developments and Future Plans
Figure 26. Covance Recent Developments and Future Plans
Figure 27. GE Healthcare Recent Developments and Future Plans
Figure 28. Quest Diagnostics Inc. Recent Developments and Future Plans
Figure 29. Thermo Fisher Scientific Inc. Recent Developments and Future Plans
Figure 30. Bio-Rad Laboratories Recent Developments and Future Plans
Figure 31. Catalent Pharma Solutions Recent Developments and Future Plans
Figure 32. Cyprotex Recent Developments and Future Plans
Figure 33. Agilent Technologies Recent Developments and Future Plans
Figure 34. Charles River Laboratories Recent Developments and Future Plans
Figure 35. Merck KgaA Recent Developments and Future Plans
Figure 36. Eurofins Scientific Inc. Recent Developments and Future Plans
Figure 37. Global In-vitro Toxicology Testing Revenue Share by Players in 2020
Figure 38. In-vitro Toxicology Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 39. Global Top 3 Players In-vitro Toxicology Testing Revenue Market Share in 2020
Figure 40. Global Top 10 Players In-vitro Toxicology Testing Revenue Market Share in 2020
Figure 41. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 42. Global In-vitro Toxicology Testing Revenue Share by Type in 2020
Figure 43. Global In-vitro Toxicology Testing Market Share Forecast by Type (2021-2026)
Figure 44. Global In-vitro Toxicology Testing Revenue Share by Application in 2020
Figure 45. Global In-vitro Toxicology Testing Market Share Forecast by Application (2021-2026)
Figure 46. North America In-vitro Toxicology Testing Sales Market Share by Type (2016-2026)
Figure 47. North America In-vitro Toxicology Testing Sales Market Share by Application (2016-2026)
Figure 48. North America In-vitro Toxicology Testing Revenue Market Share by Country (2016-2026)
Figure 49. United States In-vitro Toxicology Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. Canada In-vitro Toxicology Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. Mexico In-vitro Toxicology Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. Europe In-vitro Toxicology Testing Sales Market Share by Type (2016-2026)
Figure 53. Europe In-vitro Toxicology Testing Sales Market Share by Application (2016-2026)
Figure 54. Europe In-vitro Toxicology Testing Revenue Market Share by Country (2016-2026)
Figure 55. Germany In-vitro Toxicology Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. France In-vitro Toxicology Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. United Kingdom In-vitro Toxicology Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. Russia In-vitro Toxicology Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. Italy In-vitro Toxicology Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Asia-Pacific In-vitro Toxicology Testing Sales Market Share by Type (2016-2026)
Figure 61. Asia-Pacific In-vitro Toxicology Testing Sales Market Share by Application (2016-2026)
Figure 62. Asia-Pacific In-vitro Toxicology Testing Revenue Market Share by Region (2016-2026)
Figure 63. China In-vitro Toxicology Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Japan In-vitro Toxicology Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. South Korea In-vitro Toxicology Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. India In-vitro Toxicology Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. Southeast Asia In-vitro Toxicology Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. Australia In-vitro Toxicology Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. South America In-vitro Toxicology Testing Sales Market Share by Type (2016-2026)
Figure 70. South America In-vitro Toxicology Testing Sales Market Share by Application (2016-2026)
Figure 71. South America In-vitro Toxicology Testing Revenue Market Share by Country (2016-2026)
Figure 72. Brazil In-vitro Toxicology Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. Argentina In-vitro Toxicology Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. Middle East and Africa In-vitro Toxicology Testing Sales Market Share by Type (2016-2026)
Figure 75. Middle East and Africa In-vitro Toxicology Testing Sales Market Share by Application (2016-2026)
Figure 76. Middle East and Africa In-vitro Toxicology Testing Revenue Market Share by Country (2016-2026)
Figure 77. Turkey In-vitro Toxicology Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 78. Saudi Arabia In-vitro Toxicology Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 79. UAE In-vitro Toxicology Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 80. Methodology
Figure 81. Research Process and Data Source